![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. 5-(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylic Acid, 2-(phenyl(phenylmethyl)amino) Ethyl Ester, P-oxide, Hydrochloride
2. Efonidipine
3. Enfonidipine Hydrochloride
4. Nz 105
5. Nz-105
1. 111011-76-8
2. Efonidipine Hydrochloride Monoethanolate
3. Efonidipine Hydrochloride Ethanol
4. Landel
5. Nz 105 Ethanolate
6. Efonidipine.hcl Ethanolate
7. Efonidipine (hydrochloride Monoethanolate)
8. 84hj0q6tmn
9. Nz-105
10. 2-(n-benzylanilino)ethyl 5-(5,5-dimethyl-2-oxo-1,3,2lambda5-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate;ethanol;hydrochloride
11. 3-pyridinecarboxylicacid,1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-1,3,2-dioxa
12. Efonidipine Hydrochloride Ethanolate (jan)
13. Efonidipine Hydrochloride Ethanolate [jan]
14. Efonidipine Hcl Ethanolate
15. Unii-84hj0q6tmn
16. Landel (tn)
17. Ethanol, Compd. With 2-(phenyl(phenylmethyl)amino)ethyl 5-(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate P-oxide Monohydrochloride (1:1)
18. Ethanol, Compd. With 2-(phenyl(phenylmethyl)amino)ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate Monohydrochloride
19. Mls004712053
20. Schembl909286
21. Dtxsid5020150
22. Chebi:31532
23. Bcp33396
24. Ex-a4000
25. Nz-105 Hydrochloride Monoethanolate
26. Efonidipine Hcl Monoethanolate
27. Hy-12502a
28. S5898
29. Akos024457778
30. Cs-3622
31. 2-[phenyl(phenylmethyl)amino]ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate - Ethanol (1:1) Hydrochloride
32. 3-pyridinecarboxylic Acid, 1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-4-(3-nitrophenyl)-, 2-(phenyl(phenylmethyl)amino)ethyl Ester, P-oxide, Monohydrochloride
33. 3-pyridinecarboxylic Acid, 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(phenyl(phenylmethyl)amino)ethyl Ester, Monohydrochloride, Compd. With Ethanol (1;1)
34. As-17272
35. Smr003475016
36. C71370
37. D01604
38. Efonidipine Hydrochloride Ethanolate [mi]
39. (+/-)-efonidipine Hydrochloride Ethanolate
40. A907952
41. Q27269529
42. Efonidipine Hydrochloride Monoethanolate, >=98% (hplc)
43. 2-(benzyl(phenyl)amino)ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate Compound With Ethanol (1:1) Hydrochloride
44. 2-(benzyl(phenyl)amino)ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate Ethanol Hydrochloride
45. 3-pyridinecarboxylic Acid, 5-(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(phenyl(phenylmethyl)amino)ethyl Ester, P-oxide, Monohydrochloride, Compd. With Ethanol (1:1)
46. 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylic Acid 2-[phenyl(phenylmethyl)amino]ethyl Ester Hydrochloride Monoethanolate
47. Efonidipine Hydrochloride Monoethanolate;efonidipine Hcl H2o;nz-105 Hydrochloride Monoethanolate
Molecular Weight | 714.2 g/mol |
---|---|
Molecular Formula | C36H45ClN3O8P |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 10 |
Exact Mass | 713.2632801 g/mol |
Monoisotopic Mass | 713.2632801 g/mol |
Topological Polar Surface Area | 143 Ų |
Heavy Atom Count | 49 |
Formal Charge | 0 |
Complexity | 1170 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Diuretics
Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)